Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 5 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Soft co-processors to provide a software service function off-load architecture in a multi-core processing environment
Safety device and method for electric heating appliances
Strongly bound carbon nanotube arrays directly grown on substrates and methods for production thereof
Implant for performance enhancement of selected transistors in an integrated circuit
Fast carrier allocation in multi-carrier systems
Paging of a user equipment (UE) within a wireless communications system
  Randomly Featured Patents
Patterning on surface with high thermal conductivity materials
Composition containing inorganic porous crystals-hydrophilic macromolecule composite and product made therefrom
High-power low-noise voltage-controlled oscillator
Method and kit for assembling marine propulsion systems
Liquid crystal display device
Multi-layer body structure for the reinforcement of a panel and a method of reinforcing a panel
Sighting device
Method and apparatus for producing a multiple-blend cigarette
Necked-in can body and apparatus for making same
Semiconductor chip having multiple independent memory sections, at least one of which includes simultaneously accessible arrays